Dental Anesthesia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Local, General, and Sedation), By Route of Administration (Intra-Oral v/s Extra-Oral), By End User (Dental Hospitals, Dental Laboratories, and Others), By Region and Competition

According to the Journal of the American Dental Association (JADA), sports-related dental injuries account for 13-39% of all dental injuries in the United States.

The choice of anesthesia depends on the nature of the procedure, the patient's medical history, and the patient's level of anxiety. While dental anesthesia is generally considered safe, there are some potential risks and side effects. These include allergic reactions, nerve damage, and post-operative pain. Patients should discuss the risks and benefits of dental anesthesia with their dentist and ensure that they provide a complete medical history to avoid any potential complications. Dental anesthesia products are subject to strict regulations and require approval from regulatory agencies before they can be marketed and sold. Compliance with regulatory requirements can be time-consuming and expensive, which may pose a challenge for some companies operating in the market. Dental anesthesia can have adverse effects and safety concerns, particularly when administered improperly or in excessive amounts. Concerns over the safety and efficacy of dental anesthesia can impact consumer confidence and hinder market growth. Despite the growing demand for dental procedures, many people still lack access to affordable dental care, particularly in low-income countries. This limits the potential market for dental anesthesia products and may pose a challenge for companies looking to expand their reach. While dental anesthesia is effective in managing pain and anxiety during dental procedures, alternative pain management techniques such as acupuncture and hypnotherapy are gaining popularity. These alternative techniques may pose a threat to the growth of the dental anesthesia market. Many patients and healthcare providers are not aware of the benefits of dental anesthesia or may have misconceptions about its safety and efficacy. This lack of awareness can hinder market growth by limiting demand for the product. Dental anesthesia can be expensive, particularly for patients without insurance coverage. The high cost of dental anesthesia may limit its accessibility to some patients and impact market growth.

Growing demand for Painless Surgeries

More than 26% of adults are suffering from tooth decay in the United States.

Development in Oral Care and Dentistry

According to the WHO, Global Oral Health Status Report (2022) estimated that oral diseases affect around 3.5 billion people worldwide, with 3 out of 4 people affected living in middle-income countries and an estimated 2 billion people suffer from caries of permanent teeth and 514 million children suffer from caries of primary teeth.

Recent Development

• In 2022, 3M Technologies launched a new product for the dental sector which makes bonding even more predictable and easier in all clinical cases and the 3M stand hosted the presentation of the new Second Opinion software, which is the result of a collaboration between 3M and Pearl and provides dentists with a second opinion in diagnostic imaging, provided by an artificial intelligence tool.
• Citanest PlainIn 2019, Dentsply Sirona launched Citanest Plain, a new local anesthetic that provides fast onset and a long duration of action. The product is designed to be less acidic than other local anesthetics, reducing discomfort for patients.
• CompuDentIn 2020, Milestone Scientific launched CompuDent, a computer-controlled local anesthesia delivery system. The device uses advanced technology to provide precise and consistent anesthesia delivery, reducing the risk of over- or under-dosing.
• XyliMeltsIn 2021, OraCoat launched XyliMelts, a new topical anesthetic that provides extended pain relief for patients undergoing dental procedures. The product is designed to be placed in the mouth and slowly dissolve over time, providing up to 8 hours of relief.
• MepivacaineHydrochloride InjectionIn 2021, Aurobindo Pharma USA launched MepivacaineHydrochloride Injection, a new local anesthetic indicated for use in dentistry.The product is designed to provide rapid and long-lasting pain relief, makingit suitable for a wide range of dental procedures.

Market Segmentation

The global dental anesthesia market can be segmented by type, route of administration, end user and by region. Based on type, the market can be segmented into Local, General, and Sedation. Based on route of administration, the market can be divided into Intra-Oral and Extra-Oral. Based on end user, the market can be grouped into Dental Hospitals, Dental Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among different countries, United States dominated the global dental anesthesia market on account of growing demand for painless surgeries in the country.

Market Players

Septodont, Inc., Henry Schein, Inc., Dentsply Sirona, Inc., AstraZeneca, Plc., Abbott Laboratories, Inc., Gilead Sciences, Inc., Hospira, Inc., Hikma Pharmaceuticals, Plc., 3M Company, Aspen Group